A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium
- DOI
- 10.1016/j.xops.2024.100502
- Published
- 2024-07
- Container
- Ophthalmology Science
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xops.2024.100502,
title = {A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium},
author = {Scott M. Whitcup and Kenneth N. Sall and John A. Hovanesian and Damien F. Goldberg and Olivia L. Lee and Rong Yang and Jinsong Ni},
year = {2024},
journal = {Ophthalmology Science},
doi = {10.1016/j.xops.2024.100502},
url = {https://doi.org/10.1016/j.xops.2024.100502}
}RIS
TY - JOUR TI - A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium AU - Scott M. Whitcup AU - Kenneth N. Sall AU - John A. Hovanesian AU - Damien F. Goldberg AU - Olivia L. Lee AU - Rong Yang AU - Jinsong Ni PY - 2024 JO - Ophthalmology Science DO - 10.1016/j.xops.2024.100502 UR - https://doi.org/10.1016/j.xops.2024.100502 ER -
APA
Whitcup, S. M., Sall, K. N., Hovanesian, J. A., Goldberg, D. F., Lee, O. L., Yang, R., & Ni, J. (2024). A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium. Ophthalmology Science. https://doi.org/10.1016/j.xops.2024.100502
Source records
- crossref · retrieved 2026-09-27T02:13:04.232Z